Impact of the Minimum Pricing Policy and introduction of brand (generic) substitution into the Pharmaceutical Benefits Scheme in Australia.
about
Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policiesPharmaceutical policies: effects of reference pricing, other pricing, and purchasing policiesPhysicians' Trust in the FDA's Use of Product-Specific Pathways for Generic Drug ApprovalInfluence of mandatory generic substitution on pharmaceutical sales patterns: a national study over five years.Special challenges for drug adherence following generic substitution in Pakistani immigrants living in Norway.Attitudes of Slovene general practitioners towards generic drug prescribing and comparison with international studies.Exploring the opinions and experiences of patients with generic substitution: a representative study of Polish societyWhat impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries.Exploring knowledge and perceptions of generic medicines among drug retailers and community pharmacists.A comparison between senior medical students' and pharmacy pre-registrants' knowledge and perceptions of generic medicines.Consumers' perception of generic substitution in Iran.Perceptions and behaviors of patients and pharmacists towards generic drug substitution in Lebanon.Do Pharmacists Adhere to Brand Substitution Guidelines? The Example of Simvastatin
P2860
Q24193097-66B4D632-0E51-4FCD-B9CB-7046EF8857EDQ24246148-6CC788ED-48B6-4F20-AF38-267FA315CA13Q28552883-36835DF0-8497-4843-BA14-571B8F3EAE74Q33321951-E761E72B-9994-4350-AD01-66685F6B70DCQ34494595-527D32EB-481E-4777-B5E6-E93ABD2D699EQ34573407-35203BC5-138A-44B3-A518-982C54004BE0Q35033209-C612D77E-2E2C-4F2A-B407-BF658BC5F752Q36699426-DFF3445F-F516-4E5C-8417-03816EB26767Q36943781-BB7E3F31-27DB-491D-BCE8-840AE5820A26Q40197033-C632764A-E2A4-4476-8A85-28D1E3F8581AQ47675163-CEF71146-F5BF-4D1E-8DF1-E7896765F56CQ53551713-F6D0F962-A951-4B34-9B66-BCD7FB57E868Q57305034-0AE52649-06F1-45AC-9EFB-95C4FFB86F84
P2860
Impact of the Minimum Pricing Policy and introduction of brand (generic) substitution into the Pharmaceutical Benefits Scheme in Australia.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Impact of the Minimum Pricing ...... Benefits Scheme in Australia.
@en
Impact of the Minimum Pricing Policy and introduction of brand
@nl
type
label
Impact of the Minimum Pricing ...... Benefits Scheme in Australia.
@en
Impact of the Minimum Pricing Policy and introduction of brand
@nl
prefLabel
Impact of the Minimum Pricing ...... Benefits Scheme in Australia.
@en
Impact of the Minimum Pricing Policy and introduction of brand
@nl
P2093
P356
P1476
Impact of the Minimum Pricing ...... Benefits Scheme in Australia.
@en
P2093
P304
P356
10.1002/PDS.603
P577
2001-06-01T00:00:00Z